ERBB2 and lung carcinoma: In solid tumors, ErbB2/HER2 overexpression is a well-known driver of breast cancer as well as colon cancer, and EGFR overexpression is commonly observed in lung cancer and head and neck cancers (Blume-Jensen and Hunter, 2001; Baselga, 2006).